FDA Clearance Tracker · DEN220026
VasQ
Last checked: Nov 19, 2026Latest source record: Sep 26, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 26, 2023
De Novo granted
Time to decision
515 days
Received Apr 29, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN220026
- Device name
- VasQ
- Applicant
- Laminate Medical Technologies , Ltd.
- Applicant location
- Tel Aviv, IL
- Received
- Apr 29, 2022
- Decided
- Sep 26, 2023
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.4600
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN220026
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Laminate Medical Technologies , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VasQ510(k)
K240119 · Decided Feb 16, 2024 · 31 days after receipt
Device type: Extravascular Support For An Arteriovenous Fistula For Vascular Access (QVQ) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.